Michael N. Needle

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

Leonard B. Saltz, Neal J. Meropol, Patrick J. Loehrer et al. · Journal of Clinical Oncology · 2004 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +16

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas

R. J. Packer, Jeffrey C. Allen, Peter C. Phillips∥ et al. · Journal of neurosurgery · 1997 · 639 citations

Medicine, Oncology, Pediatrics +16

A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

Vassilios I. Avramis, Susan Sencer, Antonia Periclou et al. · Blood · 2002 · 494 citations

Medicine, Oncology, Pediatrics +10

Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

Henry Q. Xiong, Arthur Rosenberg, Albert F. LoBuglio et al. · Journal of Clinical Oncology · 2004 · 482 citations · Full text

Medicine, Oncology, Pharmacology +16

Concurrent Cetuximab, Cisplatin, and Concomitant Boost Radiotherapy for Locoregionally Advanced, Squamous Cell Head and Neck Cancer: A Pilot Phase II Study of a New Combined-Modality Paradigm

David G. Pfister, Yungpo Bernard Su, Dennis H. Kraus et al. · Journal of Clinical Oncology · 2006 · 298 citations

Medicine, Oncology, Pharmacology +17